Cart
0
Orders
REVOLAX product image

REVOLAX

Compare REVOLAX Fine, Deep and Sub-Q with lidocaine: ACROSS HA fillers in 1.1 mL syringes, with formulation and packaging details for professional buyers.
★0(0)
Main Composition
Cross-Linked Hyaluronic Acid (HA) 24 mg/mL, Lidocaine Hydrochloride 3 mg/mL
Country of Origin
South Korea

Product Range


REVOLAX
Fine
$ 39
1.1 mL
1 Syringe / 1 Box
Not available here
i
REVOLAX
Deep
$ 39
1.1 mL
1 Syringe / 1 Box
Not available here
i
REVOLAX
Sub-Q
$ 39
1.1 mL
1 Syringe / 1 Box
Not available here
i

Details about REVOLAX


Product Overview

REVOLAX Fine with Lidocaine is a cross-linked hyaluronic acid dermal filler manufactured by ACROSS CO., LTD in South Korea. The Fine formulation contains hyaluronic acid 24 mg/mL and lidocaine hydrochloride 3 mg/mL in a 1.1 mL syringe. This product page compares Fine with the Deep and Sub-Q lidocaine formulations, helping professional buyers distinguish the named gels, their documented specifications and the packaging details to check before procurement.

Key Features

  • Defined composition: Fine contains cross-linked hyaluronic acid 24 mg/mL and lidocaine hydrochloride 3 mg/mL.
  • 1.1 mL presentation: The documented Fine package contains one syringe and two needles.
  • Non-animal-origin HA: Fine is a sterile cross-linked hyaluronic acid gel intended for single use.
  • Three gel options: Fine, Deep and Sub-Q share the documented ingredient concentrations but have different brand-described gel characteristics.

Composition & Specifications

REVOLAX Fine with Lidocaine specifications
SpecificationDetails
Product categoryHyaluronic acid dermal filler
Hyaluronic acidCross-linked hyaluronic acid 24 mg/mL
Lidocaine ingredientLidocaine hydrochloride 3 mg/mL
FormulationSterile, non-animal-origin cross-linked HA gel
Syringe volume1.1 mL
Documented packageOne syringe and two needles
ManufacturerACROSS CO., LTD
Country of manufactureSouth Korea

How Hyaluronic Acid Gel Works

Hyaluronic acid gels bind water and provide a physical filling effect. This general ingredient mechanism does not establish a particular clinical outcome or treatment duration for REVOLAX Fine, Deep or Sub-Q. Matching HA concentrations alone should not be interpreted as evidence that different named gels have identical material properties.

Compare Fine, Deep & Sub-Q

Each named lidocaine formulation has documented cross-linked HA 24 mg/mL, lidocaine hydrochloride 3 mg/mL and a 1.1 mL syringe presentation. Each documented package contains one syringe and two needles. The gel descriptions below are qualitative brand descriptions, not standardized rheological measurements or treatment recommendations.

FormulationCatalog identifierBrand-described distinctionSyringe volume
REVOLAX Fine with Lidocaine110 / revol-finelidoLightest, thinnest gel in the range1.1 mL
REVOLAX Deep with Lidocaine177 / revol-deeplidoThicker gel than Fine1.1 mL
REVOLAX Sub-Q with Lidocaine178 / revol-subqlidoMost viscous gel in the range1.1 mL

Catalog identifiers are store references, not manufacturer REF or UDI codes. Confirm the exact formulation, market-specific carton and supplied accessories against the product label before procurement.

Storage & Handling

The documented storage range for Fine, Deep and Sub-Q with Lidocaine is 2–25°C. Protect the products from sunlight and freezing. Each is intended for single use. Follow the instructions supplied with the exact product and check the printed expiry date.

Frequently Asked Questions

Does this comparison include lidocaine-free REVOLAX?

No. This page covers Fine, Deep and Sub-Q with Lidocaine only. Do not apply these composition or volume specifications to a differently labeled formulation.

Which packaging details should buyers check?

Confirm the full formulation name, syringe volume, supplied needle specification, batch number, expiry date and market-specific instructions on the actual carton. Store SKU strings do not replace manufacturer product identifiers.

Who should assess these products for use?

Dermal fillers require appropriately trained healthcare professionals and carry potentially serious vascular risks. Buyers must establish local eligibility and product authorization; this comparison does not establish permission to purchase or use the products in every country.

Reviews

★0(0)

Loading reviews...